Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P (Q53986252)
scientific article
Language:
Current Data About Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P
(P31) (Q13442814)
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P50) (Q39793026)
(P248)

(Q63847562)
(P1545) 4
(P1932) Fischl MA
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P304) 1019-1030
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P407) (Q1860)

(P433) 12
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P478) 124
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P577) Saturday, June 1, 1996
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P921) (Q12199)

(Q181600)

(Q269829)
(P887)

(Q422606)
(P887)

(Q263713)
(P887)

(Q198504)
(P887)

(P1433) (Q564416)
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P1476) "Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P" (language: en)
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

(P2093) D'Aquila RT
(P1545) 1
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Hughes MD
(P1545) 2
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Johnson VA
(P1545) 3
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Sommadossi JP
(P1545) 5
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Liou SH
(P1545) 6
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Timpone J
(P1545) 7
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Myers M
(P1545) 8
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Basgoz N
(P1545) 9
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Niu M
(P1545) 10
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

Hirsch MS
(P1545) 11
(P248)
(P698) 8633815
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633815

other details
description scientific article

External Links
(P356) 10.7326/0003-4819-124-12-199606150-00001
(P698) 8633815